Formulation appears in the blood approximately 2.5 minutes after dosing. Fiasp is now approved in the US for both mealtime use and continuous infusion via pump.
FDA Approvals
This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.
Leave a Reply